4 Results for "

Rp-cAMPS

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Rp-cAMPS" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-100530D
CAS No.: 142439-94-9
Purity:  99.69%
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS sodium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS sodium salt is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-100530
CAS No.: 151837-09-1
Purity:  99.53%
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS triethylammonium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS triethylammonium salt is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
Cat. No.: HY-100530A
CAS No.: 73208-40-9
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
Cat. No.: HY-182503
CAS No.: 144928-48-3
Target:  

Adenosine Kinase

Research Areas:  

Others Inflammation/Immunology

GP515 is a potent and selective adenosine kinase inhibitor with a human IC50 of 4 nM. GP515 exerts tissue protective effects, produces long-lasting hepatic microcirculation effects after hemorrhagic shock, and induces dose- and time-related VEGF mRNA and protein expression in normoxic rat myocardial myoblasts, with additive VEGF increases during mild hypoxia and no effect during severe hypoxia. GP515 suppresses IFNγ synthesis and CD69 expression in DSS-induced colitis. GP515 also shows a dose-dependent suppression of TNF-α production with an IC50 of 80 μM and can be reversed in the presence of the cAMP antagonist (Rp)-cAMPS. Combinations of GP515 with either adenosine or rolipram led to an additive inhibition of TNF-α synthesis. GP515 can be used for the research of hemorrhagic shock .
loading...
    loading...